Clinical trial
Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment…
NCT00378404 · Susanne Arnold, Other · Terminated
Key facts
| NCT number | NCT00378404 |
|---|---|
| Title | Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC |
| Official title | A Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Susanne Arnold, Other |
| Collaborators | Kentucky Lung Cancer Research Program |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Docetaxel, Radiation |
| Enrollment | 10 |
| Start date | Nov 1, 2004 |
| Primary completion | Jun 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Sep 20, 2006 |
| Last update posted | Jun 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: